L-rhamnose as a source of colonic propionate inhibits insulin secretion but does not influence measures of appetite or food intake

Appetite. 2016 Mar 1:98:142-9. doi: 10.1016/j.appet.2015.12.011. Epub 2015 Dec 17.

Abstract

Activation of free fatty acid receptor (FFAR)2 and FFAR3 via colonic short-chain fatty acids, particularly propionate, are postulated to explain observed inverse associations between dietary fiber intake and body weight. Propionate is reported as the predominant colonic fermentation product from l-rhamnose, a natural monosaccharide that resists digestion and absorption reaching the colon intact, while effects of long-chain inulin on appetite have not been extensively investigated. In this single-blind randomized crossover study, healthy unrestrained eaters (n = 13) ingested 25.5 g/d l-rhamnose, 22.4 g/d inulin or no supplement (control) alongside a standardized breakfast and lunch, following a 6-d run-in to investigate if appetite was inhibited. Postprandial qualitative appetite, breath hydrogen, and plasma glucose, insulin, triglycerides and non-esterified fatty acids were assessed for 420 min, then an ad libitum meal was provided. Significant treatment x time effects were found for postprandial insulin (P = 0.009) and non-esterified fatty acids (P = 0.046) with a significantly lower insulin response for l-rhamnose (P = 0.023) than control. No differences between treatments were found for quantitative and qualitative appetite measures, although significant treatment x time effects for meal desire (P = 0.008) and desire to eat sweet (P = 0.036) were found. Breath hydrogen was significantly higher with inulin (P = 0.001) and l-rhamnose (P = 0.009) than control, indicating colonic fermentation. These findings suggest l-rhamnose may inhibit postprandial insulin secretion, however neither l-rhamnose or inulin influenced appetite.

Keywords: Appetite; Inulin-type fructans; Postprandial insulin; Satiety; Short-chain fatty acids.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Appetite / drug effects*
  • Blood Glucose / metabolism
  • Body Mass Index
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Colon / drug effects*
  • Colon / metabolism
  • Cross-Over Studies
  • Dietary Carbohydrates / administration & dosage
  • Dietary Fats / administration & dosage
  • Dietary Fiber / administration & dosage
  • Dietary Proteins / administration & dosage
  • Dietary Supplements
  • Energy Intake*
  • Fatty Acids, Nonesterified / blood
  • Female
  • Glucagon-Like Peptide 1 / metabolism
  • Humans
  • Insulin / metabolism*
  • Insulin Resistance
  • Insulin Secretion
  • Inulin / administration & dosage
  • Male
  • Middle Aged
  • Peptide YY / metabolism
  • Postprandial Period / drug effects
  • Propionates / blood*
  • Receptors, Cell Surface / metabolism
  • Receptors, G-Protein-Coupled / metabolism
  • Rhamnose / administration & dosage*
  • Single-Blind Method
  • Waist Circumference
  • Young Adult

Substances

  • Blood Glucose
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Dietary Carbohydrates
  • Dietary Fats
  • Dietary Fiber
  • Dietary Proteins
  • FFA2R protein, human
  • FFAR3 protein, human
  • Fatty Acids, Nonesterified
  • Insulin
  • Propionates
  • Receptors, Cell Surface
  • Receptors, G-Protein-Coupled
  • Peptide YY
  • Glucagon-Like Peptide 1
  • Inulin
  • Rhamnose